-Advertisement-
-Advertisement-
Inherited Retinal Disease
Real-world study shows positive outcomes for gene therapy in patients with RPE65-IRD
Treatment with voretigene neparvovec (VN, Luxturna) in patients with RPE65-IRD (retinal pigment epithelium 65-inherited retinal dystrophy) shows promising outcomes, according to a real-world study. The retrospective study conducted at a single center included 30 eyes from 19 patients, with a median follow-up of 15 months. The treatment demonstrated stability in...
Read More-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
Videos
24 Jul, 2023
Despite the benefits of genetic testing, there are limitations and...
-Advertisement-
-Advertisement-
Stay Connected! Join Our Newsletter
Contact
Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809
+908-505-8899
[email protected]
© 2023 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved